. . . . . email * . . . http://lm360.us/Mill-father-of-Mergen-from-Niemcz?Onofriofa=217 .may 18, 2018 . .despite neutral imaging results, adalimumab did improve other key markers of inflammation in the blood including glyca, crp, tnf, and il-6. .